ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,968Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 910

$617K Total Retail Price of All Prescriptions

Rank: 103 out of 910

1,025 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,025 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 1,025 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,095 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
AMLODIPINE BESYLATE 794 782 1 4
SIMVASTATIN 766 725 2 3
LEVOTHYROXINE SODIUM 736 710 3 1
ATENOLOL 552 528 4 10
LISINOPRIL 502 462 5 2
HYDROCODONE-ACETAMINOPHEN 488 426 S3 6 8
OMEPRAZOLE 487 451 7 5
ALENDRONATE SODIUM 413 402 8 22
GABAPENTIN 286 252 9 13
WARFARIN SODIUM 265 253 10 11
METFORMIN HCL 264 263 11 6
ZOLPIDEM TARTRATE 230 212 12 17
HYDROCHLOROTHIAZIDE 213 208 13 12
METOPROLOL TARTRATE 207 207 14 7
PAROXETINE HCL 204 194 15 50
TRIAMTERENE-HCTZ 192 182 16 39
PANTOPRAZOLE SODIUM 192 187 16 27
LOSARTAN POTASSIUM 192 187 16 15
ENALAPRIL MALEATE 191 187 19 60
METOPROLOL SUCCINATE 182 179 20 21
FUROSEMIDE 165 165 21 9
POTASSIUM CHLORIDE 160 153 22 18
TRAMADOL HCL 155 139 23 25
PRAVASTATIN SODIUM 147 133 24 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 134 25 44
GLIPIZIDE 132 123 26 38
FLUTICASONE PROPIONATE 127 118 27 23
SERTRALINE HCL 122 116 28 24
DILTIAZEM ER 112 108 29 105
ATORVASTATIN CALCIUM 110 103 30 14
DIGOXIN 103 103 31 64
LOVASTATIN 97 89 32 20
TERAZOSIN HCL 92 84 33 61
LIPITOR 91 83 34 97
RANITIDINE HCL 89 80 35 28
ZOSTAVAX 87 85 36 160
FLUOXETINE HCL 87 76 36 49
LANTUS 85 81 38 30
DONEPEZIL HCL 84 75 39 32
PROAIR HFA 74 69 40 40
INSULIN SYRINGE 73 66 41 47
OXYBUTYNIN CHLORIDE ER 73 70 41 111
NABUMETONE 71 70 43 293
NAMENDA 70 70 44 57
PLAVIX 69 68 45 53
CLOPIDOGREL 66 65 46 35
FORTICAL 65 65 47 174
ESTRADIOL 61 55 R 48 92
FLOVENT HFA 60 58 49 302
PROPRANOLOL HCL 60 57 49 120
OXYCODONE-ACETAMINOPHEN 57 56 S2 51 31
GEMFIBROZIL 56 52 52 63
ZETIA 55 55 53 84
TRAZODONE HCL 55 44 53 37
DOXYCYCLINE HYCLATE 53 50 55 117
CITALOPRAM HBR 53 47 55 19
HYDRALAZINE HCL 52 49 57 65
OXYCODONE HCL 50 34 S2 58 42
DIOVAN 50 50 58 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.